Related Experiment Video
Updated: Jan 30, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
10.5K
[NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE]
Kekkaku : [Tuberculosis]
|January 17, 2019
Summary
Nontuberculous mycobacterial (NTM) lung disease, particularly Mycobacterium avium complex (MAC), is rising globally. This report details its epidemiology, diagnosis, and treatment, highlighting areas needing further research.
Area of Science:
- Pulmonology
- Infectious Diseases
- Microbiology
Background:
- Nontuberculous mycobacterial (NTM) pulmonary disease is increasingly prevalent in Japan and worldwide.
- Mycobacterium avium complex (MAC) is the most frequent cause of NTM lung disease.
- Recognition of the importance of diagnosing and managing NTM lung disease has grown.
Purpose of the Study:
- To provide an updated overview of NTM lung disease.
- To focus on Mycobacterium avium complex (MAC) lung disease.
- To cover epidemiology, clinical features, diagnosis, and treatment strategies.
Main Methods:
- Review of current literature and clinical data on NTM lung disease.
- Analysis of epidemiological trends in Japan and globally.
- Synthesis of diagnostic approaches, including serodiagnosis.
- Examination of treatment strategies for MAC lung disease.
Main Results:
- The report synthesizes the latest epidemiological data for NTM lung disease.
- It details the clinical characteristics, disease types, and progression patterns.
- Current diagnostic methods and therapeutic interventions for MAC lung disease are presented.
Conclusions:
- NTM lung disease, especially MAC, presents a growing global health challenge.
- Comprehensive understanding of its epidemiology, clinical presentation, and progression is crucial.
- Further research is essential to address existing challenges in NTM lung disease management.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K